Understanding the Impact of Drug Shortages on Oncology Care Delivery

NCT03953027 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-04-04

No results posted yet for this study

Summary

This trial studies the impact of drug shortages on oncology care delivery. Gathering information about cancer drug shortages over time may help researchers improve access to drugs during times of shortages.

Conditions

  • Community Practice
  • Staff

Interventions

OTHER

Survey Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • University of Rochester NCORP Research Base

    lead OTHER

Principal Investigators

  • Elaine Hill, PhD · University of Rochester NCORP Research Base

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2025-06-01
Completion
2025-06-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03953027 on ClinicalTrials.gov